Peldesine Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002237
A Study of Peldesine (BCX-34) in HIV-Infected Patients